Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearables and a secure platform: can digital health reach remote patients and space?

NCT ID NCT07831837

NEW Knowledge-focused Sponsor: Laval University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers at Laval University are studying whether an integrated digital health ecosystem can support primary care patients with chronic conditions and people in remote communities. The system combines smartwatch wearables, remote monitoring, a secure digital platform, and personalized lifestyle support. About 60 adults will use the system or receive usual care for six months. The study measures usability, appropriateness, and technology acceptance, and explores whether wearable data can help assess stress. Findings may inform digital health tools for isolated environments, including future space missions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an integrated digital health ecosystem combining wearable technology, remote monitoring, a secure digital platform, and personalized lifestyle support
What this could lead to
If it works, this could help clinics and remote communities use wearable data to support self-management and stress monitoring, and inform digital health tools for future space missions.
What could go wrong
This is a small feasibility study with 60 participants, so it may not show whether the system improves health outcomes or works outside these settings. Wearables can be uncomfortable or inaccurate, and data integration may prove difficult.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Registered patient receiving care at the participating primary care clinic (GMF-U Saint-Charles-Borromée). * Have at least one stable chronic medical condition or cardiovascular risk factor requiring longitudinal follow-up. * Able to safely engage in physical activity, as determined by their treating healthcare provider. * Able to understand and communicate in English or French. * Able and willing to provide written informed consent. * Willing to comply with study procedures and scheduled follow-up visits. Exclusion Criteria: * Severe cognitive impairment or any condition preventing informed consent or study participation. * Unstable or acute medical condition requiring immediate treatment or hospitalization. * Medical contraindication to participating in physical activity, as determined by the treating healthcare * Inability to use the digital health platform or wearable device despite appropriate support. * Any condition that, in the opinion of the investigator, would compromise the participant's safety or the integrity of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digital health intervention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digital health intervention Lifestyle factors Primary care patients with chronic conditions Remote consultation, teleconsultation Space analogue Stress

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Caroline Rhéaume

    Québec, Canada

  • Université Laval

    Québec, Quebec, G1V0A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.